Literature DB >> 15899722

Personality disorders in patients with burning mouth syndrome.

Giuseppe Maina1, Umberto Albert, Sergio Gandolfo, Alberto Vitalucci, Filippo Bogetto.   

Abstract

Burning Mouth Syndrome (BMS) presents high rates of comorbid Axis I disorders while no controlled studies have addressed the question of Axis II comorbidities. The aim of the present study was to examine DSM-IV (APA, 1994) Axis II comorbidity in BMS patients and to control for the specificity of this association. Seventy BMS patients were compared to a nonpsychiatric population sample and to patients with other Somatoform Disorders for the presence of personality disorders (assessed with the Structured Clinical Interview for DSM-IV Axis II Personality Disorders [SCID-II; First, Gibbon, Spitzer, & Williams, 1997). Prevalence rates were compared using the Pearson's chi square test. At least one personality disorder (PD) was found in 85.7%, 24.3%, and 88.6% of subjects in the three groups, respectively. When examining PD subgroups, significant differences emerged even between the BMS and the somatoform disorder group, with BMS patients showing more Cluster A and fewer Cluster B PDs. Our results suggest that BMS is associated with a specific pattern of Axis II comorbidity.

Entities:  

Mesh:

Year:  2005        PMID: 15899722     DOI: 10.1521/pedi.19.1.84.62182

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  13 in total

1.  Proinflammatory cytokine levels in saliva in patients with burning mouth syndrome before and after treatment with low-level laser therapy.

Authors:  Sonja Pezelj-Ribarić; Lumnije Kqiku; Gordana Brumini; Miranda Muhvić Urek; Robert Antonić; Davor Kuiš; Irena Glažar; Peter Städtler
Journal:  Lasers Med Sci       Date:  2012-07-08       Impact factor: 3.161

Review 2.  The A, B, C's of factitious disorder: a response to Turner.

Authors:  James C Hamilton; Marc D Feldman; Jeffrey W Janata
Journal:  Medscape J Med       Date:  2009-01-27

Review 3.  Burning mouth syndrome.

Authors:  Grigoriy E Gurvits; Amy Tan
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

4.  The low level laser therapy in the management of neurological burning mouth syndrome. A pilot study.

Authors:  Umberto Romeo; Alessandro Del Vecchio; Mauro Capocci; Claudia Maggiore; Maurizio Ripari
Journal:  Ann Stomatol (Roma)       Date:  2010-06-29

5.  Peculiar alexithymic traits in burning mouth syndrome: case-control study.

Authors:  Roberto Marino; Rocco Luigi Picci; Giovanni Ferro; Claudio Carezana; Sergio Gandolfo; Monica Pentenero
Journal:  Clin Oral Investig       Date:  2015-02-14       Impact factor: 3.573

6.  Correlation between Burning Mouth Syndrome and Anxiety in the Elderly Inmates of Sanitaria in Tehran.

Authors:  Sedighe Bakhtiari; Hamid Reza Khalighi; Somayyeh Azimi; Kaveh Alavi; Hasan Ayoobi Valoogerdi; Zahra Namazi
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2010-06-24

7.  Detection of salivary interleukin 2 and interleukin 6 in patients with burning mouth syndrome.

Authors:  Daria Simcić; Sonja Pezelj-Ribarić; Renata Grzić; Jelena Horvat; Gordana Brumini; Miranda Muhvić-Urek
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

8.  Effective group training for patients with unexplained physical symptoms: a randomized controlled trial with a non-randomized one-year follow-up.

Authors:  Lyonne N L Zonneveld; Yanda R van Rood; Reinier Timman; Cornelis G Kooiman; Adriaan Van't Spijker; Jan J V Busschbach
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

9.  A valid approach in refractory glossodynia: a single-institution 5-year experience treating with Japanese traditional herbal (kampo) medicine.

Authors:  Hideki Okamoto; Atsushi Chino; Yoshiro Hirasaki; Keigo Ueda; Masaki Raimura; Takao Namiki
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-07       Impact factor: 2.629

10.  Patients with unexplained physical symptoms have poorer quality of life and higher costs than other patient groups: a cross-sectional study on burden.

Authors:  Lyonne N L Zonneveld; Mirjam A G Sprangers; Cornelis G Kooiman; Adriaan van 't Spijker; Jan J V Busschbach
Journal:  BMC Health Serv Res       Date:  2013-12-17       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.